Shandong Kexing Bioproducts Co,.Ltd (688136.SS)
CNY 35.17
(17.23%)
CNY 35.17
(17.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 547.26 Million CNY | 116.18% |
| 2022 | 253.15 Million CNY | 191.61% |
| 2021 | -276.35 Million CNY | 64.88% |
| 2020 | -786.93 Million CNY | -1018.49% |
| 2019 | 85.67 Million CNY | 70.53% |
| 2018 | 50.24 Million CNY | 27.86% |
| 2017 | 39.29 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 500.19 Million CNY | -34.78% |
| 2024 Q1 | 839.24 Million CNY | 53.35% |
| 2024 Q2 | 794.53 Million CNY | -5.33% |
| 2023 FY | 547.26 Million CNY | 116.18% |
| 2023 Q2 | 660.93 Million CNY | 5.31% |
| 2023 Q1 | 627.59 Million CNY | 147.91% |
| 2023 Q4 | 547.26 Million CNY | -32.23% |
| 2023 Q3 | 807.54 Million CNY | 22.18% |
| 2022 Q2 | 270.98 Million CNY | 303.67% |
| 2022 FY | 253.15 Million CNY | 191.61% |
| 2022 Q4 | 253.15 Million CNY | -24.14% |
| 2022 Q3 | 333.71 Million CNY | 23.15% |
| 2022 Q1 | -133.05 Million CNY | 51.85% |
| 2021 FY | -276.35 Million CNY | 64.88% |
| 2021 Q2 | -403.4 Million CNY | -289.52% |
| 2021 Q3 | -184.5 Million CNY | 54.26% |
| 2021 Q4 | -276.35 Million CNY | -49.78% |
| 2021 Q1 | -103.56 Million CNY | 86.84% |
| 2020 Q3 | 161.93 Million CNY | 20.13% |
| 2020 FY | -786.93 Million CNY | -1018.49% |
| 2020 Q2 | 134.8 Million CNY | -10.7% |
| 2020 Q1 | 150.95 Million CNY | 76.2% |
| 2020 Q4 | -786.93 Million CNY | -585.95% |
| 2019 Q4 | 85.67 Million CNY | 0.0% |
| 2019 FY | 85.67 Million CNY | 70.53% |
| 2018 FY | 50.24 Million CNY | 27.86% |
| 2017 FY | 39.29 Million CNY | 0.0% |